{
    "id": "5ca0848aecadf2e73f000044",
    "question": "Are there any anti-amyloid antibody approved as drug for Alzheimer's disease treatment?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "B",
    "predict": "{\"step_by_step_thinking\": \"To answer this question, we need to consider the current state of Alzheimer's disease treatment and the role of anti-amyloid antibodies in this context. Alzheimer's disease is a complex neurodegenerative disorder characterized by the accumulation of amyloid-beta plaques in the brain. Theoretically, targeting amyloid-beta with antibodies could be a promising approach to slow down disease progression. However, the effectiveness and safety of anti-amyloid antibodies as a treatment for Alzheimer's disease have been a topic of ongoing research and debate. So far, several anti-amyloid antibodies have been tested in clinical trials, but none have been approved as a drug for Alzheimer's disease treatment yet. The most well-known example is aducanumab, which was approved by the FDA in 2021 for emergency use in treating early Alzheimer's disease, but its long-term efficacy and safety are still being evaluated.\", \"answer_choice\": \"A\"}",
    "snippets": [],
    "scores": [],
    "execution_time": 25.40796399116516
}